Abstract
In this study, we attempted to determine whether proton pump inhibitor (PPI) use in patients with hepatic encephalopathy was predisposed to more severe stages of hepatic encephalopathy according to West Haven criteria. We found that chronic use of PPIs in patients with cirrhosis of the liver and gastroduodenal pathology was associated with significantly higher mean West Haven criteria for hepatic encephalopathy compared with patients who did not use PPIs. Our data also showed that patients with cirrhosis of the liver receiving PPIs have longer hospital stays, with increased morbidity and mortality during their hospital stay.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Web of Scientist: International Scientific Research Journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
